Russia-based BinomixRay employs RADLogics™ Virtual Resident™ Medical Imaging AI solution to improve the accuracy, speed, and quality of Medical Imaging Interpretation by radiologists

CHICAGO, Dec. 2, 2019 /PRNewswire/ — RADLogics™ announced today at RSNA’s annual meeting that Russia-based BinomixRay has selected the RADLogics Virtual Resident™ AI solution for improving CT and X-ray diagnostics at its medical facilities in Russia. The Virtual Resident™ AI solution is commercially available in Russia and is not available for sale in the United States.

BinomixRay and RADLogics have signed a commercial agreement for the provision of the Virtual Resident AI solution, which creates initial CT and X-ray analytics within seconds to help radiologists achieve more precise diagnostics while saving substantial interpretation time. BinomixRay is a fast-developing, innovative company established in partnership with Lobachevsky State University, one of Russia’s largest institutes of higher education.

“In the era of innovation, the only bottleneck in diagnosing a disease is the human factor,” says Arie Povolotski, BinomixRay’s Chief Executive Officer. “I believe that the introduction of RADLogics AI solution can potentially improve the accuracy, quality, and speed of medical imaging diagnosis, which will increase the level of medical services provided to patients.”

RADLogics cloud-based Virtual Resident AI solution uses machine learning image analysis algorithms to search and analyze imaging data from CTs, MRIs, PET-CT, and X-rays to provide consistent, objective measurements and numeric characterization of findings. With this clinical decision support solution, radiologists can potentially realize decreased image interpretation and report creation times, as seen in a recent research study completed at UCLA, and published by Academic Radiology. Virtual Resident is not available in the U.S.

“We are honored to be one of the first companies to provide commercial AI solutions for the Russian medical imaging market,” says RADLogics’ CEO and Co-Founder Moshe Becker. Our partnership with BinomixRay allows us to streamline the introduction of our solutions to the Russian market while having a positive impact on radiologists and patients alike.”

For more information about Virtual Resident, BinomixRay, and RADLogics, visit RSNA Booth 10932 or contact Lynn Humphreys.

ABOUT RADLOGICS
A healthcare AI software company, RADLogics’s mission is to provide machine learning image analysis solutions to improve radiologists’ productivity while enhancing patient outcomes. RADLogics Virtual Resident™ solution uses machine learning image analysis and advanced big data analytics to search and analyze imaging data from CTs, MRIs, PET scans, and X-rays to help reduce diagnostics turnaround time from hours to minutes by automating detection and report generation functions.  RADLogics Virtual Resident™ solution is available in certain jurisdictions outside the United States.  In the United States, it is an investigational device limited by Federal Law to investigational use. 

MEDIA CONTACT
Lynn Humphreys
lynn@radlogics.com
Virtual Press Room 

View original content:http://www.prnewswire.com/news-releases/russia-based-binomixray-employs-radlogics-virtual-resident-medical-imaging-ai-solution-to-improve-the-accuracy-speed-and-quality-of-medical-imaging-interpretation-by-radiologists-300965864.html

SOURCE RADLogics

Staff

Recent Posts

BioHarvest Launches VINIA SuperFood Functional Tea Line

Incremental Product Launch Addresses $3.3 Billion North American Functional Tea Market Opportunity with First SuperFood…

4 minutes ago

Neurotech Innovator UNEEG Medical Receives FDA Breakthrough Device Designation Within Monitoring and Diagnostic of Epilepsy

The designation is a result of UNEEG's strong focus on developing novel disease management support…

4 minutes ago

Lexaria’s GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled

DehydraTECH-processed tirzepatide from Zepbound® is being tested in an oral dose format KELOWNA, BC /…

4 minutes ago

S4 Medical Receives FDA 510(k) Approval for its Redesigned Esophageal Deviation Device and Begins Commercialization

CHAGRIN FALLS, OH / ACCESSWIRE / November 25, 2024 / S4 Medical Corp, an Ohio…

4 minutes ago

Acreage Provides Update on Corporate Transactions

NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Acreage Holdings, Inc. ("Acreage" or…

4 minutes ago